Clinical Trial Update: Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study [Phase 4]

View source ↗

Summary

An open-label Phase 4 trial evaluating tolerability and efficacy of high-dose escitalopram in patients with obsessive-compulsive disorder and schizophrenia. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder
• Schizophrenia

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: BeerYaakov Mental Health Center | Conditions: OCD, Schizophrenia | Phase 4 | Status: UNKNOWN